Clinical trialNCT06885034RecruitingPhase 1/PHASE2Interventional

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

SponsorGlaxoSmithKlineEnrollment320Gastrointestinal Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Gsk Investigational Site
Heidelberg, Victoria, Australia
Niall Tebbutt
Recruiting
Gsk Investigational Site
Melbourne, Victoria, Australia
Jeanne Tie
Recruiting

Belgium

Gsk Investigational Site
Bonheiden, Belgium
Pieter-Jan Cuyle
Recruiting
Gsk Investigational Site
Brussels, Belgium
Marc Van den Eynde
Recruiting
Gsk Investigational Site
Leuven, Belgium
Gertjan Rasschaert
Recruiting
Gsk Investigational Site
Roeselare, Belgium
Sofie De Meulder
Recruiting

Brazil

Gsk Investigational Site
Porto Alegre, Brazil
Alan Arrieira Azambuja
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Camila Moniz
Recruiting
Gsk Investigational Site
Teresina, Brazil
Claudio Henrique Lima Rocha
Recruiting

Canada

Gsk Investigational Site
Toronto, Ontario, Canada
Eric Chen
Recruiting
Gsk Investigational Site
Sherbrooke, Quebec, Canada
Frederic Lemay
Recruiting

France

Gsk Investigational Site
Paris, France
Thomas Aparicio
Recruiting
Gsk Investigational Site
Paris, France
Thierry Andre
Recruiting
Gsk Investigational Site
Villejuif, France
Michel Ducreux
Recruiting

Italy

Gsk Investigational Site
Pisa, Italy
Chiara Cremolini
Recruiting

Japan

Gsk Investigational Site
Aichi, Japan
Kei Muro
Recruiting
Gsk Investigational Site
Chiba, Japan
Akihito Kawazoe
Recruiting
Gsk Investigational Site
Hokkaido, Japan
Yoshito Komatsu
Recruiting
Gsk Investigational Site
Osaka, Japan
Taroh Satoh
Recruiting
Gsk Investigational Site
Tokyo, Japan
Toshiharu Hirose
Recruiting
Gsk Investigational Site
Tokyo, Japan
Kensei Yamaguchi
Recruiting

Netherlands

Gsk Investigational Site
Amsterdam, Netherlands
Marieke A. Vollebergh
Recruiting
Gsk Investigational Site
Utrecht, Netherlands
Robert Jan Kwakman
Recruiting

Norway

Gsk Investigational Site
Lrenskog, Norway
Asa Dahle-Smith
Recruiting
Gsk Investigational Site
Oslo, Norway
Jorgen Smeby
Recruiting
Gsk Investigational Site
Stavanger, Norway
Herish Garresori
Recruiting

Poland

Gsk Investigational Site
Brzozów, Poland
Joanna Kiszka
Recruiting
Gsk Investigational Site
Warsaw, Poland
Lucjan Wyrwicz
Recruiting

South Korea

Gsk Investigational Site
Seoul, South Korea
Sae-Won Han
Recruiting
Gsk Investigational Site
Seoul, South Korea
Seung Tae Kim
Recruiting
Gsk Investigational Site
Seoul, South Korea
Yong Sang Hong
Recruiting

Spain

Gsk Investigational Site
Barcelona, Spain
David Paez Lopez-Bravo
Recruiting
Gsk Investigational Site
Madrid, Spain
Pilar Garcia Alfonso
Recruiting
Gsk Investigational Site
Madrid, Spain
Íñigo Martínez Delfrade
Recruiting
Gsk Investigational Site
Madrid, Spain
Maria Del Carmen Riesco Martinez
Recruiting
Gsk Investigational Site
Pamplona, Spain
Ruth Vera Garcia
Recruiting
Gsk Investigational Site
Santander, Spain
Carlos López López
Recruiting
Gsk Investigational Site
Zaragoza, Spain
Vicente Alonso Orduna
Recruiting

Sweden

Gsk Investigational Site
Lund, Sweden
Jakob Eberhard
Recruiting
Gsk Investigational Site
Stockholm, Sweden
Virginia Alvariza
Recruiting

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Jun 2025
Primary completion: 11 Nov 2027
Completion: 23 Jun 2028
Last update posted: 18 Nov 2025
Registered enrollment: 320
Registry id: NCT06885034

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-520672-26

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.